# Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events

> **NCT01968954** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 711 (actual)

## Conditions studied

- Hyperlipidemia

## Interventions

- **DRUG:** Bococizumab (PF-04950615;RN316)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01968954
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 711 (ACTUAL)
- **Last updated:** 2017-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01968954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01968954, "Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01968954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*